Martek, Neuromedica deal

The companies agreed to produce a form of Neuromedica’s Doprexin, a treatment for tardive dyskinesia, that passes through the blood-brain barrier. Doprexin is a compound formed by connecting dopamine to docosahexaenoic acid (DHA). ...